Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Amarantus Bioscience Holdi AMBS
Posted On: 10/27/2015 5:15:52 PM
Post# of 30067
Posted By: biotechmania
Does anyone know if the following scenario is possible? I'm not familiar with SEC regulations, so please let me know if it's not.

Let's say a potential partner approached AMBS and said we're willing to give you $50 million upfront for one of the DX assets (e.g. MSPrecise) and 1-2% royalty percentage on sales in exchange for keeping 98-99% of sales and 20 million AMBS shares. So in the current market, let's say AMBS provides 20 million shares at a price of $0.50/share ($10M).

When the deal is announced by AMBS, the market interprets that AMBS' valuation is much higher than $0.50/share on MSPrecise alone.

I'm wondering if AMBS went with so-called "toxic financiers" instead of LPC because toxic guys are known to convert and sell. The pps would drop as a result, but it would make the deal more attractive to the strategic partner.

Thoughts?













(0)
(0)









  • New Post - Investors HangoutNew Post

  • Public Reply - Investors HangoutPublic Reply

  • Private Reply - Investors HangoutPrivate Reply

  • Board - Investors HangoutBoard

  • More - Investors HangoutMore

  • Keep Post - Investors HangoutKeep Post
  • Report Post - Investors HangoutReport Post
  • Home - Investors HangoutHome
  • Mailbox - Investors HangoutMailbox
  • Boards - Investors HangoutBoards
  • Favorites - Investors HangoutFavorites
  • Whats Hot! - Investors HangoutWhats Hot!
  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site